phrykt

Exelixis, Inc. (EXEL): who owns it and who trades it

As of Nov 16, 2026, EXEL insiders reported 28 open-market sales worth $34.8M and 1 purchase worth $1.2M in the last 12 months, with 20% of the sale value made under pre-set 10b5-1 plans. The largest seller was Patrick J. Haley (Vice president), with $7.6M. 7 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Exelixis

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns EXEL

756 funds and institutions reported EXEL shares worth $14.5B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 11.6%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.11.6%
California State Teachers Retirement System5.9%
Farallon Capital Management, L.l.c.5.4%
Renaissance Technologies LLC5.3%
Vanguard Portfolio Management LLC4.8%
AQR Capital Management LLC4.4%
Vanguard Capital Management LLC4.4%
State Street Corp4.0%
Fuller & Thaler Asset Management, Inc.3.6%
Lsv Asset Management3.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.29.08M11.57%$1.6B-6%
California State Teachers Retirement System14.79M5.88%$272M–
Farallon Capital Management, L.l.c.13.47M5.36%$733M+3%
Renaissance Technologies LLC13.43M5.34%$731M-2%
Vanguard Portfolio Management LLC12.04M4.79%$655M-0%
AQR Capital Management LLC11.02M4.39%$599M-16%
Vanguard Capital Management LLC10.95M4.36%$596M-3%
State Street Corp9.97M3.97%$542M-3%
Fuller & Thaler Asset Management, Inc.8.93M3.55%$486M+5%
Lsv Asset Management8.15M3.24%$443M+5%
Geode Capital Management, LLC7.65M3.04%$416M-2%
D. E. Shaw & Co., Inc.5.55M2.21%$302M+54%
Morgan Stanley4.52M1.80%$246M+8%
Invesco Ltd.4.50M1.79%$245M+4%
Dimensional Fund Advisors LP4.43M1.76%$241M+3%
Arrowstreet Capital, Limited Partnership4.37M1.74%$238M-10%
Two Sigma Investments, LP4.21M1.67%$229M+91%
Assetmark, Inc3.43M1.37%$187M+1%
Nuveen, LLC3.28M1.30%$178M-13%
UBS Group AG3.17M1.26%$172M+32%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, EXEL insiders reported $1.2M of open-market purchases and $34.8M of sales. 20% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$1.2M
1 trades, 1 people
Sales, 12 months
$34.8M
28 trades, 11 people
Sales under a 10b5-1 plan
20%
Share of sale value
Latest trade
Aug 10, 2026
Filed Aug 12, 2026

Purchases and sales by month

$20.6M$20.6MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 10, 2026Mary C BeckerleDirectorSale plan9,812$53.66$527KForm 4
Jun 1, 2026Jack L WyszomierskiDirectorSale plan3,925$50.55$198KForm 4
Jun 1, 2026Sue Gail EckhardtDirectorSale plan9,812$50.14$492KForm 4
May 26, 2026Dana AftabVice presidentSale43,451$50.35$2.2MForm 4
May 20, 2026Patrick J. HaleyVice presidentSale32,110$49.81$1.6MForm 4
May 18, 2026Christopher J. SennerCFOSale34,901$50.00$1.7MForm 4
May 18, 2026Brenda HeftiVice presidentSale plan6,625$50.21$333KForm 4
May 7, 2026Mary C BeckerleDirectorSale7,712$48.45$374KForm 4
May 7, 2026Maria C FreireDirectorSale20,634$46.00$949KForm 4
May 7, 2026George PosteDirectorSale60,000$45.71$2.7MForm 4
Feb 24, 2026Dana AftabVice presidentSale47,918$44.50$2.1MForm 4
Feb 19, 2026Dana AftabVice presidentSale29,873$44.35$1.3MForm 4
Feb 18, 2026Jack L WyszomierskiDirectorSale plan99,574$44.01$4.4MForm 4
Feb 18, 2026Julie SmithDirectorSale44,087$44.50$2MForm 4
Feb 18, 2026Julie SmithDirectorSale20,030$44.30$887KForm 4
Feb 18, 2026Brenda HeftiVice presidentSale plan18,669$44.01$822KForm 4
Feb 17, 2026Julie SmithDirectorSale42,422$43.33$1.8MForm 4
Feb 17, 2026Christopher J. SennerCFOSale30,617$43.67$1.3MForm 4
Feb 17, 2026Patrick J. HaleyVice presidentSale3,036$43.84$133KForm 4
Feb 17, 2026Patrick J. HaleyVice presidentSale64,778$43.50$2.8MForm 4
Feb 13, 2026Christopher J. SennerCFOSale34,278$43.00$1.5MForm 4
Feb 13, 2026Sue Gail EckhardtDirectorSale plan3,856$43.79$169KForm 4
Feb 13, 2026Bob OliverDirectorSale21,162$43.90$929KForm 4
Feb 13, 2026Bob OliverDirectorSale9,088$43.61$396KForm 4
Nov 25, 2025Caligan Partners LP +1DirectorPurchase27,532$43.12$1.2MForm 4
Nov 21, 2025Patrick J. HaleyVice presidentSale28,043$42.58$1.2MForm 4
Nov 20, 2025Patrick J. HaleyVice presidentSale10,000$42.11$421KForm 4
Nov 20, 2025Patrick J. HaleyVice presidentSale10,648$41.77$445KForm 4
Nov 20, 2025Patrick J. HaleyVice presidentSale23,539$41.93$987KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Patrick J. HaleyEVP, Commercial–$7.6MMay 20, 2026
Dana AftabEVP, Research and Development–$5.6MMay 26, 2026
Julie SmithDirector–$4.7MFeb 18, 2026
Jack L WyszomierskiDirector–$4.6MJun 1, 2026
Christopher J. SennerEVP and CFO–$4.6MMay 18, 2026
George PosteDirector–$2.7MMay 7, 2026
Bob OliverDirector–$1.3MFeb 13, 2026
Caligan Partners LPDirector$1.2M–Nov 25, 2025
Brenda HeftiSVP and General Counsel–$1.2MMay 18, 2026
Maria C FreireDirector–$949KMay 7, 2026
Mary C BeckerleDirector–$900KAug 10, 2026
Sue Gail EckhardtDirector–$661KJun 1, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

EXEL short interest

High short interest. 10.5% of EXEL shares are sold short: about 1 share in 10. Over the last 12 reports the number of shares short went down 15%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 25.59M EXEL shares were sold short, 10.5% of the shares outstanding, down 6.3% from the report before. At the average daily volume of 2.19M shares, buying them all back would take about 11.7 trading days (days to cover).

Shares short, % of all shares

10.5%May 15Oct 3012.6%

Days to cover

11.7May 15Oct 3015.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202625.59M10.49%-6%2.19M11.7
Oct 15, 202627.31M11.02%-3%2.41M11.3
Sep 30, 202628.18M11.37%+7%2.23M12.7
Sep 15, 202626.40M10.65%-8%2.13M12.4
Aug 31, 202628.66M11.57%+2%1.93M14.9
Aug 14, 202628.03M11.31%-2%3.22M8.7
Jul 31, 202628.75M11.60%-7%2.14M13.4
Jul 15, 202630.91M12.30%+8%2.44M12.7
Jun 30, 202628.54M11.35%-7%3.33M8.6
Jun 15, 202630.64M12.19%+3%2.26M13.5
May 29, 202629.71M11.82%-2%2.40M12.3
May 15, 202630.28M12.05%+1%3.30M9.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Exelixis company events

Exelixis filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 29, 2026.

  1. Oct 29, 2026ResultsReleased financial results. Filing
  2. Sep 11, 2026AnnouncementToday, Exelixis, Inc. (Exelixis) announced that on September 10, 2026, the U.S. Food and Drug Administration (FDA) notified Exelixis that it had extended the review period for Exelixis’ new drug application (NDA) for zanzalintinib, in combination with atezolizumab, for the treatment of patients… Filing
  3. Aug 31, 2026AnnouncementExelixis, inc. Filing
  4. Aug 5, 2026ResultsReleased financial results. Filing
  5. May 29, 2026LeadershipAt the 2026 Annual Meeting of Stockholders (the Annual Meeting) of Exelixis, Inc. (Exelixis), Exelixis’ stockholders, upon recommendation of Exelixis’ Board of Directors, approved the amendment and restatement of the Exelixis, Inc. 2017 Equity Incentive Plan (as so amended and restated, the 2017… Filing
  6. May 5, 2026AnnouncementExelixis announced that the Board of Directors authorized the repurchase of up to an additional $750 million of its common stock by December 31, 2027. Filing
  7. Feb 10, 2026ResultsReleased financial results. Filing
  8. Jan 12, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Exelixis financials

Famous investors that hold EXEL

7 of the 50 well-known investors we track reported holding EXEL in their latest 13F filing. The largest position is Jim Simons's, worth $747M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 202612.79M$747M1.0%-5%
Israel Englander · Millennium ManagementQ3 2026354,857$20.7M0.0%-71%
Ray Dalio · Bridgewater AssociatesQ3 2026328,588$19.2M0.1%-18%
Ken Fisher · Fisher Asset ManagementQ3 2026214,045$12.5M0.0%+9%
Paul Tudor Jones · Tudor Investment CorpQ3 2026111,760$6.5M0.0%+2313%
Ken Griffin · Citadel AdvisorsQ3 202664,832$3.8M0.0%-9%
Lee Ainslie · Maverick CapitalQ3 20264,699$274K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named EXEL in the last 120 days.

FiledHolderFormStake
Nov 9, 2026Farallon Capital Management, L.L.C.13D/A4.9%
Nov 9, 2026Farallon Capital Management, L.L.C.13D/A4.9%
Nov 9, 2026Farallon Capital Management, L.L.C.13G6.0%
Nov 9, 2026Farallon Capital Management, L.L.C.13G6.0%

Questions about Exelixis, Inc. (EXEL) stock

Who owns the most EXEL stock?

The largest reported owner of Exelixis, Inc. (EXEL) is BlackRock, Inc., with 11.6% of the company. In total, 756 funds and institutions reported holding EXEL at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are EXEL insiders buying or selling?

In the last 12 months, EXEL insiders reported 1 open-market purchase worth $1.2M and 28 sales worth $34.8M. The latest trade was on Aug 10, 2026. See every trade.

What is the short interest in EXEL?

As of Oct 30, 2026, 25.59M EXEL shares were sold short, 10.5% of the shares outstanding, down 6.3% from the report before. At the average daily volume of 2.19M shares, buying them all back would take about 11.7 trading days (days to cover). See the history.

Which famous investors hold EXEL?

7 of the 50 well-known investors we track reported EXEL in their latest 13F filing, including Jim Simons, Israel Englander, Ray Dalio. The largest position is worth $747M. See all holders.

Executive pay

Exelixis's chief executive was paid a total of $33.2M for the year ended Jan 2, 2026, up 161% from $12.7M the year before. In the last 12 months, Exelixis's executives and directors bought no stock on the open market and sold $34.8M.

Chief executive, total pay$33.2MYear ended Jan 2, 2026. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$55.1MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$9.1MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.